Mesothelioma malignant recurrent – Treatment – Overview of Information and Clinical Research
Mesothelioma is a cancer that arises from the mesothelial cells that line the body’s serous cavities, most commonly the pleural cavities surrounding the lungs or the peritoneal cavity surrounding the abdominal organs.
Patients experiencing recurrent mesothelioma face ongoing symptom management and quality‑of‑life issues that require coordinated, tailored therapeutic strategies.
Evidence level: Klinikai vizsgálat. Formális klinikai vizsgálati eredmény.
Related signals
- Moving Beyond Morphology: Toward a Morpho‑Molecular Classification of Pleural Mesothelioma
- Comparison of Survival by Multimodal Treatment Regimen Among Malignant Pleural Mesothelioma Patients in an Integrated Health System
- Systemic Treatments for Unresectable Pleural Mesothelioma: A Review of the Literature
- Prognostic impact of somatic mutations among patients with pleural and peritoneal mesothelioma
- Tumor Treating Fields (TTFields) for Pleural Mesothelioma